192 related articles for article (PubMed ID: 10759339)
1. The effect of citalopram treatment on platelet serotonin function in panic disorders.
Neuger J; Wistedt B; Sinner B; Aberg-Wistedt A; Stain-Malmgren R
Int Clin Psychopharmacol; 2000 Mar; 15(2):83-91. PubMed ID: 10759339
[TBL] [Abstract][Full Text] [Related]
2. Effect of citalopram treatment on relationship between platelet serotonin functions and the Karolinska scales of personality in panic patients.
Neuger J; Wistedt B; Aberg-Wistedt A; Stain-Malmgren R
J Clin Psychopharmacol; 2002 Aug; 22(4):400-5. PubMed ID: 12172340
[TBL] [Abstract][Full Text] [Related]
3. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.
Bakish D; Cavazzoni P; Chudzik J; Ravindran A; Hrdina PD
Biol Psychiatry; 1997 Jan; 41(2):184-90. PubMed ID: 9018388
[TBL] [Abstract][Full Text] [Related]
4. Platelet serotonergic functions and light therapy in seasonal affective disorder.
Stain-Malmgren R; Kjellman BF; Aberg-Wistedt A
Psychiatry Res; 1998 May; 78(3):163-72. PubMed ID: 9657420
[TBL] [Abstract][Full Text] [Related]
5. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic function in major depression and effect of sertraline and paroxetine treatment.
Stain-Malmgren R; Khoury AE; Aberg-Wistedt A; Tham A
Int Clin Psychopharmacol; 2001 Mar; 16(2):93-101. PubMed ID: 11236074
[TBL] [Abstract][Full Text] [Related]
7. Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants.
Li X; Fan Y; Xiao S; Peng S; Dong X; Zheng X; Liu CC; Li H; Xiao Z
J Affect Disord; 2015 Nov; 187():84-90. PubMed ID: 26321259
[TBL] [Abstract][Full Text] [Related]
8. Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study.
Seedat S; van Rheede van Oudtshoorn E; Muller JE; Mohr N; Stein DJ
Int Clin Psychopharmacol; 2003 Sep; 18(5):279-84. PubMed ID: 12920388
[TBL] [Abstract][Full Text] [Related]
9. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor.
Esler M; Lambert E; Alvarenga M; Socratous F; Richards J; Barton D; Pier C; Brenchley C; Dawood T; Hastings J; Guo L; Haikerwal D; Kaye D; Jennings G; Kalff V; Kelly M; Wiesner G; Lambert G
Stress; 2007 Aug; 10(3):295-304. PubMed ID: 17613943
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
11. Platelet serotonin functions in untreated major depression.
Neuger J; El Khoury A; Kjellman BF; Wahlund B; Aberg-Wistedt A; Stain-Malmgren R
Psychiatry Res; 1999 Feb; 85(2):189-98. PubMed ID: 10220009
[TBL] [Abstract][Full Text] [Related]
12. Platelet serotonin transporter function after short-term paroxetine treatment in patients with panic disorder.
Kang EH; Shim HB; Kim KJ; Park JE; Lee IS; Yu BH
Psychiatry Res; 2010 Apr; 176(2-3):250-3. PubMed ID: 20207008
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.
Hrdina PD; Bakish D; Chudzik J; Ravindran A; Lapierre YD
J Psychiatry Neurosci; 1995 Jan; 20(1):11-9. PubMed ID: 7865496
[TBL] [Abstract][Full Text] [Related]
14. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
Hrdina PD; Bakish D; Ravindran A; Chudzik J; Cavazzoni P; Lapierre YD
Psychiatry Res; 1997 Feb; 66(2-3):73-85. PubMed ID: 9075272
[TBL] [Abstract][Full Text] [Related]
15. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.
Dannon PN; Iancu I; Lowengrub K; Gonopolsky Y; Musin E; Grunhaus L; Kotler M
Clin Neuropharmacol; 2007; 30(6):326-34. PubMed ID: 18090457
[TBL] [Abstract][Full Text] [Related]
16. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
Spigset O; Allard P; Mjörndal T
Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533
[TBL] [Abstract][Full Text] [Related]
17. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
Alvarez JC; Gluck N; Arnulf I; Quintin P; Leboyer M; Pecquery R; Launay JM; Perez-Diaz F; Spreux-Varoquaux O
Clin Pharmacol Ther; 1999 Dec; 66(6):617-24. PubMed ID: 10613618
[TBL] [Abstract][Full Text] [Related]
18. A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.
Perna G; Bertani A; Caldirola D; Smeraldi E; Bellodi L
Pharmacopsychiatry; 2001 May; 34(3):85-90. PubMed ID: 11434404
[TBL] [Abstract][Full Text] [Related]
19. Decreased platelet 3H-paroxetine binding in untreated panic disorder patients.
Marazziti D; Rossi A; Dell'Osso L; Palego L; Placidi GP; Giannaccini G; Lucacchini A; Cassano GB
Life Sci; 1999; 65(25):2735-41. PubMed ID: 10622283
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats.
Gobbi M; Crespi D; Foddi MC; Fracasso C; Mancini L; Parotti L; Mennini T
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):22-8. PubMed ID: 9228186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
